High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory–thrombotic processes

Tatiana Koudriavtseva, Giovanna D’Agosto, Chiara Mandoj, Isabella Sperduti, Paola Cordiali-Fei

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The exact prevalence and pathogenic role of antiphospholipid antibodies (aPL) in multiple sclerosis (MS) remain unclear. This observational laboratory-blinded study evaluated the rate of aPL positivity in healthy controls and MS patients in different disease phases to recognize their frequency and possible pathogenic meaning. Reactivity for anti-cardiolipin, anti-β2 glycoprotein I, anti-prothrombin, anti-annexin V (IgG and IgM) was studied by enzyme immunoassays in 60 healthy controls and 100 consecutive MS patients [58 relapsing–remitting (RR) patients in remission, 26 RR patients in relapse, and 16 secondary progressive patients]. The overall rate of positivity for at least one aPL was significantly higher in MS patients compared to controls (32 % vs. 7 %, respectively, p 

Original languageEnglish
Pages (from-to)1737-1741
Number of pages5
JournalNeurological Sciences
Volume35
Issue number11
DOIs
Publication statusPublished - 2014

Fingerprint

Antiphospholipid Antibodies
Multiple Sclerosis
Recurrence
Cardiolipins
Annexin A5
Prothrombin
Immunoenzyme Techniques
Immunoglobulin M
Glycoproteins
Immunoglobulin G

Keywords

  • Antiphospholipid antibodies
  • Beta 2-glycoprotein-I
  • Multiple Sclerosis
  • Prothrombin
  • Relapse

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this

High frequency of antiphospholipid antibodies in relapse of multiple sclerosis : a possible indicator of inflammatory–thrombotic processes. / Koudriavtseva, Tatiana; D’Agosto, Giovanna; Mandoj, Chiara; Sperduti, Isabella; Cordiali-Fei, Paola.

In: Neurological Sciences, Vol. 35, No. 11, 2014, p. 1737-1741.

Research output: Contribution to journalArticle

Koudriavtseva, Tatiana ; D’Agosto, Giovanna ; Mandoj, Chiara ; Sperduti, Isabella ; Cordiali-Fei, Paola. / High frequency of antiphospholipid antibodies in relapse of multiple sclerosis : a possible indicator of inflammatory–thrombotic processes. In: Neurological Sciences. 2014 ; Vol. 35, No. 11. pp. 1737-1741.
@article{83dbcaa9caeb47deb1f528b081761553,
title = "High frequency of antiphospholipid antibodies in relapse of multiple sclerosis: a possible indicator of inflammatory–thrombotic processes",
abstract = "The exact prevalence and pathogenic role of antiphospholipid antibodies (aPL) in multiple sclerosis (MS) remain unclear. This observational laboratory-blinded study evaluated the rate of aPL positivity in healthy controls and MS patients in different disease phases to recognize their frequency and possible pathogenic meaning. Reactivity for anti-cardiolipin, anti-β2 glycoprotein I, anti-prothrombin, anti-annexin V (IgG and IgM) was studied by enzyme immunoassays in 60 healthy controls and 100 consecutive MS patients [58 relapsing–remitting (RR) patients in remission, 26 RR patients in relapse, and 16 secondary progressive patients]. The overall rate of positivity for at least one aPL was significantly higher in MS patients compared to controls (32 {\%} vs. 7 {\%}, respectively, p ",
keywords = "Antiphospholipid antibodies, Beta 2-glycoprotein-I, Multiple Sclerosis, Prothrombin, Relapse",
author = "Tatiana Koudriavtseva and Giovanna D’Agosto and Chiara Mandoj and Isabella Sperduti and Paola Cordiali-Fei",
year = "2014",
doi = "10.1007/s10072-014-1823-4",
language = "English",
volume = "35",
pages = "1737--1741",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "11",

}

TY - JOUR

T1 - High frequency of antiphospholipid antibodies in relapse of multiple sclerosis

T2 - a possible indicator of inflammatory–thrombotic processes

AU - Koudriavtseva, Tatiana

AU - D’Agosto, Giovanna

AU - Mandoj, Chiara

AU - Sperduti, Isabella

AU - Cordiali-Fei, Paola

PY - 2014

Y1 - 2014

N2 - The exact prevalence and pathogenic role of antiphospholipid antibodies (aPL) in multiple sclerosis (MS) remain unclear. This observational laboratory-blinded study evaluated the rate of aPL positivity in healthy controls and MS patients in different disease phases to recognize their frequency and possible pathogenic meaning. Reactivity for anti-cardiolipin, anti-β2 glycoprotein I, anti-prothrombin, anti-annexin V (IgG and IgM) was studied by enzyme immunoassays in 60 healthy controls and 100 consecutive MS patients [58 relapsing–remitting (RR) patients in remission, 26 RR patients in relapse, and 16 secondary progressive patients]. The overall rate of positivity for at least one aPL was significantly higher in MS patients compared to controls (32 % vs. 7 %, respectively, p 

AB - The exact prevalence and pathogenic role of antiphospholipid antibodies (aPL) in multiple sclerosis (MS) remain unclear. This observational laboratory-blinded study evaluated the rate of aPL positivity in healthy controls and MS patients in different disease phases to recognize their frequency and possible pathogenic meaning. Reactivity for anti-cardiolipin, anti-β2 glycoprotein I, anti-prothrombin, anti-annexin V (IgG and IgM) was studied by enzyme immunoassays in 60 healthy controls and 100 consecutive MS patients [58 relapsing–remitting (RR) patients in remission, 26 RR patients in relapse, and 16 secondary progressive patients]. The overall rate of positivity for at least one aPL was significantly higher in MS patients compared to controls (32 % vs. 7 %, respectively, p 

KW - Antiphospholipid antibodies

KW - Beta 2-glycoprotein-I

KW - Multiple Sclerosis

KW - Prothrombin

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=84939871590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939871590&partnerID=8YFLogxK

U2 - 10.1007/s10072-014-1823-4

DO - 10.1007/s10072-014-1823-4

M3 - Article

C2 - 24847961

AN - SCOPUS:84939871590

VL - 35

SP - 1737

EP - 1741

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 11

ER -